These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11762517)

  • 1. Factors affecting the deposition of aerosolized insulin.
    Katz IM; Schroeter JD; Martonen TB
    Diabetes Technol Ther; 2001; 3(3):387-97. PubMed ID: 11762517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good Things in Small Packages: an Innovative Delivery Approach for Inhaled Insulin.
    Fink JB; Molloy L; Patton JS; Galindo-Filho VC; de Melo Barcelar J; Alcoforado L; Brandão SCS; de Andrade AD
    Pharm Res; 2017 Dec; 34(12):2568-2578. PubMed ID: 28718049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY; Wang CH
    J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters.
    Martonen TB; Katz IM
    Pharm Res; 1993 Jun; 10(6):871-8. PubMed ID: 8321856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled insulin--does it become reality?
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling breath-enhanced jet nebulizers to estimate pulmonary drug deposition.
    Wee WB; Leung K; Coates AL
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):387-96. PubMed ID: 23509934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalation, deposition, and fate of insulin and other therapeutic proteins.
    Brain JD
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S4-S15. PubMed ID: 17563302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the deposition of inhaled porous drug particles.
    Musante CJ; Schroeter JD; Rosati JA; Crowder TM; Hickey AJ; Martonen TB
    J Pharm Sci; 2002 Jul; 91(7):1590-600. PubMed ID: 12115821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin disposition in the lung following oral inhalation in humans : a meta-analysis of its pharmacokinetics.
    Sakagami M
    Clin Pharmacokinet; 2004; 43(8):539-52. PubMed ID: 15170368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Models of Inhalation Therapy in Early Childhood: Therapeutic Aerosols in the Developing Acinus.
    Katan JT; Hofemeier P; Sznitman J
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):288-98. PubMed ID: 26907858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin lung deposition and clearance following Technosphere® insulin inhalation powder administration.
    Cassidy JP; Amin N; Marino M; Gotfried M; Meyer T; Sommerer K; Baughman RA
    Pharm Res; 2011 Sep; 28(9):2157-64. PubMed ID: 21491144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle deposition in children's lungs: theory and experiment.
    Isaacs KK; Martonen TB
    J Aerosol Med; 2005; 18(3):337-53. PubMed ID: 16181008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deposition of coarse particles in cystic fibrosis: model predictions versus experimental results.
    Brown JS; Bennett WD
    J Aerosol Med; 2004; 17(3):239-48. PubMed ID: 15625816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-micro- and nanoparticles for pulmonary delivery.
    Klingler C; Müller BW; Steckel H
    Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical model for the selective deposition of inhaled pharmaceuticals.
    Martonen TB
    J Pharm Sci; 1993 Dec; 82(12):1191-9. PubMed ID: 8308694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory flow phenomena and gravitational deposition in a three-dimensional space-filling model of the pulmonary acinar tree.
    Sznitman J; Heimsch T; Wildhaber JH; Tsuda A; Rösgen T
    J Biomech Eng; 2009 Mar; 131(3):031010. PubMed ID: 19154069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action.
    Henkin RI
    Nutrition; 2010 Jan; 26(1):33-9. PubMed ID: 20005465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling particle deposition in human lungs: modelling concepts and comparison with experimental data.
    Hofmann W
    Biomarkers; 2009 Jul; 14 Suppl 1():59-62. PubMed ID: 19604061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of particle size and aerosolization time on the metabolic effect of an inhaled insulin aerosol.
    Kapitza C; Heise T; Fishman RS; Shapiro DA; Gopalakrishnan V; Rave K; Bott S; Perera AD; Heinemann L
    Diabetes Technol Ther; 2004 Apr; 6(2):119-27. PubMed ID: 15117578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.